| Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia A Taher, F El Rassi, H Isma’eel, S Koussa, A Inati, MD Cappellini Haematologica 93 (10), 1584-1586, 2008 | 143 | 2008 |
| Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey … I Osunkwo, B Andemariam, CP Minniti, BPD Inusa, F El Rassi, ... American Journal of Hematology 96 (4), 404-417, 2021 | 102 | 2021 |
| Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia H Isma'eel, AH El Chafic, F El Rassi, A Inati, S Koussa, R Daher, ... The American journal of cardiology 102 (3), 363-367, 2008 | 60 | 2008 |
| Does post-transplant maintenance therapy with tyrosine kinase inhibitors improve outcomes of patients with high-risk Philadelphia chromosome-positive leukemia? Z DeFilipp, AA Langston, Z Chen, C Zhang, ML Arellano, F El Rassi, ... Clinical Lymphoma Myeloma and Leukemia 16 (8), 466-471. e1, 2016 | 45 | 2016 |
| Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia AN Saliba, F El Rassi, AT Taher Expert review of hematology 9 (2), 151-168, 2016 | 38 | 2016 |
| Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, ... Cancer 119 (21), 3784-3787, 2013 | 35 | 2013 |
| Venous access catheter-related thrombosis in patients with cancer M Gaddh, A Antun, K Yamada, P Gupta, H Tran, F El Rassi, HS Kim, ... Leukemia & Lymphoma 55 (3), 501-508, 2014 | 30 | 2014 |
| Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma Z Mitri, MT Siddiqui, F El Rassi, JT Holden, LT Heffner, A Langston, ... Leukemia & Lymphoma 55 (7), 1498-1500, 2014 | 29 | 2014 |
| Update on optimal management of acute myeloid leukemia FE Rassi, M Arellano Clinical Medicine Insights: Oncology 7, CMO. S8528, 2013 | 29 | 2013 |
| Iron overload in patients with myelodysplastic syndromes: an updated overview NM Moukalled, FA El Rassi, SN Temraz, AT Taher Cancer 124 (20), 3979-3989, 2018 | 28 | 2018 |
| Beta-thalassemia intermedia: an overview MD Fuad El Rassi, MD Cappellini, A Inati, A Taher Pediatric Annals 37 (5), 322, 2008 | 26 | 2008 |
| Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ... Transfusion 59 (5), 1698-1705, 2019 | 22 | 2019 |
| Predicting early blast transformation in chronic‐phase chronic myeloid leukemia: Is immunophenotyping the missing link? F El Rassi, JD Bergsagel, M Arellano, M Gaddh, A Jillella, V Kota, ... Cancer 121 (6), 872-875, 2015 | 20 | 2015 |
| Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia FE Rassi, HJ Khoury Pharmacogenomics and personalized medicine, 57-62, 2013 | 18 | 2013 |
| A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis CD Dampier, MJ Telen, T Wun, RC Brown, P Desai, F El Rassi, B Fuh, ... Blood 141 (2), 168-179, 2023 | 16 | 2023 |
| Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia? JH Kong, EF Winton, LT Heffner, Z Chen, AA Langston, B Hill, M Arellano, ... Cancer 123 (13), 2482-2488, 2017 | 14 | 2017 |
| Early initiation of treatment with rivipansel for acute vaso-occlusive crisis in sickle cell disease (SCD) achieves earlier discontinuation of IV opioids and shorter hospital … CD Dampier, MJ Telen, T Wun, WR Smith, RC Brown, P Desai, ... Blood 136, 18-19, 2020 | 13 | 2020 |
| Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease JP Haydek, C Taborda, R Shah, PA Reshamwala, ML McLemore, ... World Journal of Hepatology 11 (3), 287, 2019 | 12 | 2019 |
| Outcomes of chronic phase chronic myeloid leukemia after treatment with multiple tyrosine kinase inhibitors JH Kong, EF Winton, LT Heffner, M Gaddh, B Hill, J Neely, A Hatcher, ... Journal of Clinical Medicine 9 (5), 1542, 2020 | 9 | 2020 |
| Advances in hematopoietic stem cell transplantation in chronic myeloid leukemia R Veldman, F El Rassi, S Holloway, A Langston, HJ Khoury Discovery Medicine 16 (88), 179-186, 2013 | 7 | 2013 |
